Olivia's Feed
Jun 5, 2015

Teva raises its stake in acquisition target Mylan

By Olivia Oran

(Reuters) – Teva Pharmaceutical Industries Ltd (TEVA.TA: Quote, Profile, Research, Stock Buzz) has increased its stake in Mylan NV (MYL.O: Quote, Profile, Research, Stock Buzz) to nearly 2.2 percent as it presses on with an unsolicited bid for its generic drug-making rival, a regulatory filing showed on Friday.

The strategy is another sign of Teva’s commitment to its $40 billion takeover proposal for Mylan, as the latter continues to pursue its own hostile bid for over-the-counter drug company Perrigo Company PLC (PRGO.N: Quote, Profile, Research, Stock Buzz).

Jun 2, 2015

Exclusive: Teva poised to raise its stake in Mylan – sources

By Olivia Oran

(Reuters) – Teva Pharmaceutical Industries Ltd (TEVA.TA: Quote, Profile, Research, Stock Buzz) is looking to buy more shares in Mylan NV (MYL.O: Quote, Profile, Research, Stock Buzz), positioning itself for a possible legal challenge to the generics drugmaker that has spurned its takeover bid, people familiar with the matter said.

The strategy is a sign of Teva’s commitment to its $40 billion bid for Mylan, as the latter presses on with its own $34 billion hostile bid for over-the-counter drug company Perrigo Company Plc (PRGO.N: Quote, Profile, Research, Stock Buzz).

Jun 2, 2015

Teva poised to raise its stake in Mylan -sources

By Olivia Oran

(Reuters) – Teva Pharmaceutical Industries Ltd is
looking to buy more shares in Mylan NV, positioning
itself for a possible legal challenge to the generics drugmaker
that has spurned its takeover bid, people familiar with the
matter said.

The strategy is a sign of Teva’s commitment to its $40
billion bid for Mylan, as the latter presses on with its own $34
billion hostile bid for over-the-counter drug company Perrigo
Company Plc.

May 29, 2015

Health insurer Humana explores sale – source

May 29 (Reuters) – Humana Inc is considering selling
itself after receiving multiple expressions of takeover
interest, a person familiar with the matter said on Friday,
highlighting the potential for further consolidation in the U.S.
health insurance industry.

Humana is working with investment bank Goldman Sachs Group
Inc on the potential sale, the person said, asking not to
be identified because the matter is confidential.

May 26, 2015

Exclusive: Gourmet sandwich chain Jimmy John’s prepares IPO – sources

By Olivia Oran

(Reuters) – Jimmy John’s Franchise LLC is preparing for an initial public offering that could value the popular U.S. gourmet sandwich chain at more than $2 billion, including debt, according to people familiar with the matter.

Jimmy John’s, which is owned by founder Jimmy John Liautaud as well as private equity firm Weston Presidio, is interviewing investment banks to serve as underwriters for an IPO that could come later this year, three people said.

May 26, 2015

Gourmet sandwich chain Jimmy John’s prepares IPO -sources

May 26 (Reuters) – Jimmy John’s Franchise LLC is preparing
for an initial public offering that could value the popular U.S.
gourmet sandwich chain at more than $2 billion, including debt,
according to people familiar with the matter.

Jimmy John’s, which is owned by founder Jimmy John Liautaud
as well as private equity firm Weston Presidio, is interviewing
investment banks to serve as underwriters for an IPO that could
come later this year, three people said.

May 21, 2015

Goldman Sachs asks shareholders to ‘like’ tech push in San Francisco

SAN FRANCISCO, May 21 (Reuters) – In Goldman Sachs Group
Inc’s latest move to bolster its street cred as a cool,
tech-savvy bank, it is holding its annual shareholder meeting in
San Francisco on Thursday.

Goldman has been one of the top investment banks handling
mergers and IPOs for the tech sector since the dot-com boom of
the 1990s. But more recently, the bank has been trying to mold
itself into a tech firm of sorts, too.

May 18, 2015

Abandoning Par IPO for $8 billion sale could help TPG with its own

By Greg Roumeliotis and Olivia Oran

(Reuters) – TPG Capital LP may have helped its own campaign to go public after pulling Par Pharmaceutical Holdings Inc’s IPO.

TPG was preparing to begin an IPO investor roadshow for Par Pharmaceutical Holdings before it agreed to sell the generics drugmaker to Endo International Plc (ENDP.O: Quote, Profile, Research, Stock Buzz) for around $8 billion. TPG bought Par for $1.9 billion in 2012.

May 11, 2015

Exclusive: Apollo in talks to buy ASG Security, combine with other firm – sources

By Mike Stone and Olivia Oran

(Reuters) – Apollo Global Management Llc (APO.N: Quote, Profile, Research, Stock Buzz) is in talks to buy ASG Security and combine it with another home security company it is acquiring, Protection 1, valuing them collectively at about $2 billion, people familiar with the matter said on Monday.

Final bids for ASG Security are due on Monday, the sources said. Reuters reported in February that Apollo was in the lead to acquire Protection 1 from buyout firm GTCR Llc for about $1.5 billion. The deal has been finalized, contingent upon Apollo also clinching a deal for ASG, the people said.

May 11, 2015

Apollo in talks to buy ASG Security, combine with other firm-sources

May 11 (Reuters) – Apollo Global Management Llc is
in talks to buy ASG Security and combine it with another home
security company it is acquiring, Protection 1, valuing them
collectively at about $2 billion, people familiar with the
matter said on Monday.

Final bids for ASG Security are due on Monday, the sources
said. Reuters reported in February that Apollo was in the lead
to acquire Protection 1 from buyout firm GTCR Llc for about $1.5
billion. The deal has been finalized, contingent upon Apollo
also clinching a deal for ASG, the people said.